This trial is testing a new treatment for amyloidosis, a disease where amyloid protein builds up in the body's organs.
1 Primary · 3 Secondary · Reporting Duration: Month 9
Experimental Treatment
Non-Treatment Group
150 Total Participants · 2 Treatment Groups
Primary Treatment: Standard of Care Chemotherapy · Has Placebo Group · Phase 3
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: